Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Atropine sulfate ophthalmic - Sydnexis

Next Previous
Drug Profile

Atropine sulfate ophthalmic - Sydnexis

Alternative Names: Ryjunea; STN-1012701; SYD 101

Latest Information Update: 13 Jun 2025

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Sydnexis
  • Class Alcohols; Alkaloids; Antidotes; Azabicyclo compounds; Bridged bicyclo compounds; Cardiovascular therapies; Esters; Eye disorder therapies; Propanols; Small molecules; Toluenes; Tropanes
  • Mechanism of Action Cholinergic receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Registered Myopia

Most Recent Events

  • 06 Jun 2025 Registered for Myopia (In adolescents, In children) in Iceland, Norway, Liechtenstein, European Union (Ophthalmic)
  • 01 Apr 2025 Preregistration for Myopia (In adolescents, In children) in European Union (Ophthalmic)
  • 01 Apr 2025 European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) grants positive opinion for Atropine sulfate ophthalmic in Myopia (In adolescents, In children)

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top